Through a continued relationship with Journey Clinical, we now offer Spravato in addition to previously offered forms of Ketamine Assisted Therapy.
What is Spravato? Spravato (esketamine) is the only FDA-approved nasal spray for adults with treatment-resistant depression — meaning depression that has not responded to oral antidepressant medications. It can produce: Relief possible within 24-hours42% full remission at 16 weeksOnly FDA-approved nasal spray for TRD
Accepted insurance for Spravato? We are currently able to accept United Healthcare, Optum, UMR , Florida Blue, Cigna, and Curative. This list will continue to grow.
